Diagnostic Accuracy of Doppler Ultrasound and Role of Uterine Artery Doppler
NCT ID: NCT03530475
Last Updated: 2018-05-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2018-05-22
2018-08-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
All of those patients are presenting during the period of may 2018 to july 2018 to Kasr-Al Ainy Obstetrics outpatient clinic or casualty department during their 3rd trimester.
All of them will be assorted according to certain inclusion and exclusion criterions as follow:
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diagnostic Accuracy of Placental Thickness in Lower Uterine Segment Measured By Ultrasound in Prediction of Placenta Accreta Spectrum in Patients With Placenta Previa. A Diagnostic Test Accuracy Study
NCT05500404
3D Placental Volume in Placenta Accreta
NCT06755047
Ultrasound in Prediction of Operative Findings in Cesarean Section Among Placenta Accreta Cases
NCT03286998
Sonographic Parameters and Risk of Antepartum Hemorrhage in Asymptomatic Women With Placenta Previa: A Cohort Study
NCT05802251
Study of the Vascularity of Uterine Septum Using Three Dimensional Power Doppler Ultrasound
NCT03792438
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Those patients are attending to Kasr-Al Ainy Obstetrics outpatient clinic or casualty department during their 3rd trimester.
Ultrasound and doppler will be done to all patients to diagnose placenta accreta . The diagnosis will be confirmed by intraoperative assessments and histopathological examination of the uterus after cesarean hysterectomy
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
placenta previa
cases diagnosed as placenta previa diagnosed by ultrasound and doppler
ultrasound and doppler
• Ultrasound examination (2D gray scale and color doppler )
1\. Confirming the presence of placenta previa 2,To assess the possibility of concomitant placenta accreta (Sonographic findings that have been associated with placenta accreta (1) Loss of normal hypoechoic retroplacental zone (2) Multiple vascular lacunae (irregular vascular spaces) within placenta, (3) Blood vessels or placental tissue bridging uterine-placental margin, myometrial-bladder interface, or crossing uterine serosa1 (4) Retroplacental myometrial thickness of 1 mm (5) Bladder wall interruption (6) Presence of placental bulge (7) Utero-vesical hypervascularity (8) presence of lacunae feeder vessels.
3\. Assessment of uterine artery Doppler in different cases of placenta previa.
. Documentation of the operative findings during cesarean section and/or cesarean hysterectomy procedures.
Histopathological examination of the hysterectomy specimens to assess the degree of myometrial invasion.
placenta accreta
placenta previa diagnosed as placenta accreta by ultrasound and doppler
ultrasound and doppler
• Ultrasound examination (2D gray scale and color doppler )
1\. Confirming the presence of placenta previa 2,To assess the possibility of concomitant placenta accreta (Sonographic findings that have been associated with placenta accreta (1) Loss of normal hypoechoic retroplacental zone (2) Multiple vascular lacunae (irregular vascular spaces) within placenta, (3) Blood vessels or placental tissue bridging uterine-placental margin, myometrial-bladder interface, or crossing uterine serosa1 (4) Retroplacental myometrial thickness of 1 mm (5) Bladder wall interruption (6) Presence of placental bulge (7) Utero-vesical hypervascularity (8) presence of lacunae feeder vessels.
3\. Assessment of uterine artery Doppler in different cases of placenta previa.
. Documentation of the operative findings during cesarean section and/or cesarean hysterectomy procedures.
Histopathological examination of the hysterectomy specimens to assess the degree of myometrial invasion.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ultrasound and doppler
• Ultrasound examination (2D gray scale and color doppler )
1\. Confirming the presence of placenta previa 2,To assess the possibility of concomitant placenta accreta (Sonographic findings that have been associated with placenta accreta (1) Loss of normal hypoechoic retroplacental zone (2) Multiple vascular lacunae (irregular vascular spaces) within placenta, (3) Blood vessels or placental tissue bridging uterine-placental margin, myometrial-bladder interface, or crossing uterine serosa1 (4) Retroplacental myometrial thickness of 1 mm (5) Bladder wall interruption (6) Presence of placental bulge (7) Utero-vesical hypervascularity (8) presence of lacunae feeder vessels.
3\. Assessment of uterine artery Doppler in different cases of placenta previa.
. Documentation of the operative findings during cesarean section and/or cesarean hysterectomy procedures.
Histopathological examination of the hysterectomy specimens to assess the degree of myometrial invasion.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Single living fetus.
* One or more cesarean section or hysterotomy.
* Placenta previa (all grades) with high possibility of morbidly adherent placenta accreta (all types).
Exclusion Criteria
* Pregnancy induced disorders (pre-eclampsia or gestational diabetes).
* Associated fetal anomalies.
20 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kasr El Aini Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
hala nabil
principle investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hala Nabil, M.D
Role: PRINCIPAL_INVESTIGATOR
Cairo University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5000
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.